For: | Srinivasan S, Tampi RR, Balaram K, Kapoor A. Pimavanserin for the treatment of psychosis in Alzheimer’s disease: A literature review. World J Psychiatr 2020; 10(7): 162-174 [PMID: 32844093 DOI: 10.5498/wjp.v10.i7.162] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v10/i7/162.htm |
Number | Citing Articles |
1 |
Biljana Nigović. New approach on sensitive analysis of pimavanserin, levodopa and entacapone based on synergistic effect of graphene nanoplatelets and graphitized carbon nanotubes in functionalized polymer matrix. Electrochimica Acta 2023; 439: 141700 doi: 10.1016/j.electacta.2022.141700
|
2 |
Yuriy M. Kositsyn, Murilo S. de Abreu, Tatiana O. Kolesnikova, Alexey A. Lagunin, Vladimir V. Poroikov, Hasmik S. Harutyunyan, Konstantin B. Yenkoyan, Allan V. Kalueff. Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies. International Journal of Molecular Sciences 2023; 24(11): 9482 doi: 10.3390/ijms24119482
|
3 |
Maria Paula Maziero, Natalia P. Rocha, Antonio L. Teixeira. Antipsychotics in Alzheimer’s Disease: Current Status and Therapeutic
Alternatives. Current Alzheimer Research 2023; 20(10): 682 doi: 10.2174/0115672050287534240215052417
|
4 |
Lea Danics, Anna Anoir Abbas, Balázs Kis, Karolina Pircs. Fountain of youth—Targeting autophagy in aging. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1125739
|
5 |
Faruk Kurhan, Mustafa Akın. A New Hope in Alzheimer's Disease Psychosis: Pimavanserin. Current Alzheimer Research 2023; 20(6): 403 doi: 10.2174/1567205020666230825124922
|
6 |
Andrea de Bartolomeis, Mariateresa Ciccarelli, Licia Vellucci, Michele Fornaro, Felice Iasevoli, Annarita Barone. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia. Expert Opinion on Pharmacotherapy 2022; 23(18): 2035 doi: 10.1080/14656566.2022.2145884
|
7 |
Benoit Mulsant, Bruce Pollock. The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry. 2022; doi: 10.1176/appi.books.9781615375196.ds20
|
8 |
Matej Ľupták, Danica Michaličková, Zdeněk Fišar, Eva Kitzlerová, Jana Hroudová. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets. World Journal of Psychiatry 2021; 11(7): 277-296 doi: 10.5498/wjp.v11.i7.277
|
9 |
Bhawana Sharma, Saumya Das, Avijit Mazumder, Deepraj Singh Rautela, Pankaj Kumar Tyagi, Navneet Khurana. The role of neurotransmitter receptors in antipsychotic medication efficacy for Alzheimer’s-related psychosis. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 2024; 60(1) doi: 10.1186/s41983-024-00848-2
|
10 |
Ghazal Davodi-Boroujerdi, Ayda Khayyat Naghadehi, Farzaneh Nazari-Serenjeh, Sakineh Alijanpour, Zahra Ghasemzadeh, Ali Rastqar. Protective Roles of Melatonin in Alzheimer's Disease: A Review of Experimental and Clinical Research. Jentashapir Journal of Cellular and Molecular Biology 2024; 15(1) doi: 10.5812/jjcmb-139844
|